Systematic Review with Meta-analysis: Association of Helicobacter pylori Infection with Esophageal Cancer

被引:45
作者
Gao, Huiqin [1 ,2 ]
Li, Lunan [2 ]
Zhang, Chenjing [1 ]
Tu, Jiangfeng [1 ]
Geng, Xiaoge [1 ]
Wang, Jingya [1 ]
Zhou, Xiaolu [1 ]
Jing, Jiyong [3 ]
Pan, Wensheng [1 ]
机构
[1] Hangzhou Med Coll, Peoples Hosp, Zhejiang Prov Peoples Hosp, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China
[2] Bengbu Med Coll, Bengbu, Anhui, Peoples R China
[3] Hangzhou Med Coll, Peoples Hosp, Zhejiang Prov Peoples Hosp, Hangzhou, Zhejiang, Peoples R China
关键词
SQUAMOUS-CELL CARCINOMA; GASTRIC ATROPHY; BARRETTS-ESOPHAGUS; SERUM PEPSINOGENS; INCREASED RISK; ADENOCARCINOMA; SEROPOSITIVITY; PREVALENCE; ANTIBODIES; SYMPTOMS;
D O I
10.1155/2019/1953497
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. Helicobacter pylori is an important carcinogenic factor in gastric cancer. Studies have shown that Helicobacter pylori infection is inversely associated with certain diseases such as esophageal cancer and whose infection appears to have a "protective effect." At present, the relationship between Helicobacter pylori infection and esophageal cancer remains controversial. This study was designed to investigate the relationship between Helicobacter pylori infection and the risk of esophageal cancer in different regions and ethnicities. Methods. Systematic search of the articles on the relationship between Helicobacter pylori infection and esophageal cancer from the database with the duration time up to December 2018. This systematic review was performed under the MOOSE guidelines. Results. This meta-analysis included 35 studies with 345,886 patients enrolled. There was no significant correlation between Helicobacter pylori infection and esophageal squamous cell carcinoma in the general population (OR: 0.84; 95% CI: 0.64-1.09/OR: 0.74; 95% CI: 0.54-0.97). However, a significant correlation was found in the Middle East (OR: 0.34; 95% CI: 0.22-0.52/95% CI: 0.26-0.44). There was no significant difference in the prevalence of Helicobacter pylori between the case group and the control group in esophageal adenocarcinoma (8.87% vs. 9.67%). The pooled OR was 0.55 (95% CI: 0.43-0.70) or 0.23 (95% CI: 0.15-0.36). When grouped by match or not, the pooled OR of the nonmatching group and the matching group was 0.48/0.21 (95% CI: 0.36-0.65/95% CI: 0.13-0.36) and 0.73/0.71 (95% CI: 0.57-0.92/95% CI: 0.60-0.84), respectively. Conclusion. In the general populations, no significant association was found between Helicobacter pylori infection and the risk of esophageal squamous cell carcinoma. However, lower risk was found in the Middle East. Helicobacter pylori infection may reduce the risk of esophageal adenocarcinoma, but such "protection effect" may be overestimated.
引用
收藏
页数:17
相关论文
共 71 条
[1]   Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia [J].
Anandasabapathy, Sharmila ;
Jhamb, Jagriti ;
Davila, Marta ;
Wei, Caimiao ;
Morris, Jeffrey ;
Bresalier, Robert .
CANCER, 2007, 109 (04) :668-674
[2]   Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence:: results from the FINBAR case-control study [J].
Anderson, L. A. ;
Murphy, S. J. ;
Johnston, B. T. ;
Watson, R. G. P. ;
Ferguson, H. R. ;
Bamford, K. B. ;
Ghazy, A. ;
McCarron, P. ;
McGuigan, J. ;
Reynolds, J. V. ;
Comber, H. ;
Murray, L. J. .
GUT, 2008, 57 (06) :734-739
[3]  
Chow WH, 1998, CANCER RES, V58, P588
[4]   The Epidemiology of Esophageal Adenocarcinoma [J].
Coleman, Helen G. ;
Xie, Shao-Hua ;
Lagergren, Jesper .
GASTROENTEROLOGY, 2018, 154 (02) :390-405
[5]   Serum Pepsinogens and Helicobacter pylori in Relation to the Risk of Esophageal Squamous Cell Carcinoma in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study [J].
Cook, Michael B. ;
Dawsey, Sanford M. ;
Diaw, Lena ;
Blaser, Martin J. ;
Perez-Perez, Guillermo I. ;
Abnet, Christian C. ;
Taylor, Philip R. ;
Albanes, Demetrius ;
Virtamo, Jarmo ;
Kamangar, Farin .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (08) :1966-1975
[6]  
Daugule Ilva, 2015, World J Methodol, V5, P203, DOI 10.5662/wjm.v5.i4.203
[7]   Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma [J].
de Martel, C ;
Llosa, AE ;
Farr, SM ;
Friedman, GD ;
Vogelman, JH ;
Orentreich, N ;
Corley, DA ;
Parsonnet, J .
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (05) :761-767
[8]  
Deeks J.J., 2019, Cochrane Handbook for Systematic Reviews of Interventions, P241, DOI [10.1002/9781119536604.ch10, DOI 10.1002/9781119536604.CH10, 10.1002/9780470712184.ch9, DOI 10.1002/9780470712184.CH9, DOI 10.1002/9781119536604]
[9]   Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer [J].
Derakhshan, M. H. ;
Malekzadeh, R. ;
Watabe, H. ;
Yazdanbod, A. ;
Fyfe, V. ;
Kazemi, A. ;
Rakhshani, N. ;
Didevar, R. ;
Sotoudeh, M. ;
Zolfeghari, A. A. ;
McColl, K. E. L. .
GUT, 2008, 57 (03) :298-305
[10]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188